Atlas Trials

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

Clinical trial NCT00233441 · COMPLETED

Trial details

NCT number
NCT00233441
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Atrial FibrillationAtrial Flutter
Start date
2004-12-01
Primary completion
2006-05-01
Enrollment
673

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.